Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 2Phase 3 1

Status

Withdrawn 1Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1CNS 1

Conditions

Leukemia, Myeloid, Acute 197Leukemia 110Lymphoma 90Precursor Cell Lymphoblastic Leukemia-Lymphoma 86Burkitt Lymphoma 52Myelodysplastic Syndromes 47Lymphoma, Mantle-Cell 47Lymphoma, Large B-Cell, Diffuse 47Lymphoma, Non-Hodgkin 46Leukemia, Myelomonocytic, Acute 30Lymphoma, Follicular 29Leukemia, Monocytic, Acute 29Recurrence 25Congenital Abnormalities 25Leukemia, Erythroblastic, Acute 24Lymphoma, Large-Cell, Immunoblastic 23Leukemia, Megakaryoblastic, Acute 23Blast Crisis 21Hodgkin Disease 20Leukemia, Lymphocytic, Chronic, B-Cell 18Leukemia, Myelomonocytic, Chronic 17Leukemia, Myelogenous, Chronic, BCR-ABL Positive 17Lymphoma, B-Cell, Marginal Zone 15Anemia, Refractory, with Excess of Blasts 15Leukemia, Myeloid, Accelerated Phase 13Leukemia, Biphenotypic, Acute 13Leukemia, Myeloid, Chronic-Phase 12Dendritic Cell Sarcoma, Interdigitating 12Myeloproliferative Disorders 11Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 10

Interventions

Amifostine 10Cisplatin 8Radiotherapy 7Etoposide 6Cyclophosphamide 4Carboplatin 4Paclitaxel 3pegfilgrastim 2camrelizumab 2apatinib 2Mitoxantrone 2Filgrastim 2Drug Therapy 2Cytarabine 2sodium thiosulfate 1sargramostim 1pazopanib 1icotinib 1glucarpidase 1etoposide phosphate 1denileukin diftitox 1Vitamin E 1Triptorelin Pamoate 1Tocopherols 1Thiotepa 1Tegafur 1Taxes 1Surgical Procedures, Operative 1Silymarin 1Rituximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Drug-Related Side Effects and Adverse Reactions × Cytarabine × Clear all
NCT00074165 2023-07-06

Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimen

OHSU Knight Cancer Institute

Phase 2 Terminated
17 enrolled 7 charts
CNSClassical hematologyLymphoid

Lymphoma, Thrombocytopenia, Central Nervous System Neoplasms, Intraocular Lymphoma, Drug-Related Side Effects and Adverse Reactions

NCT00003407 2023-02-02

Amifostine & High-Dose Combination Chemotherapy in Treating Patients With Acute ML or CML

Rush University Medical Center

Phase 2 Withdrawn
MyeloidOther hematologic neoplasm

Blast Crisis, Leukemia, Myelodysplastic Syndromes, Neutropenia, Leukemia, Myeloid, Acute, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡